iTeos Therapeutics Appoints Scott Chappel as Chief Scientific Officer
03 juil. 2018 07h00 HE
|
iTeos Therapeutics SA
iTeos Therapeutics Appoints Scott Chappel as Chief Scientific Officer Gosselies, Belgium – July 3, 2018 – iTeos Therapeutics SA, a biotechnology company developing novel cancer immunotherapies, today...